Retsu Fujita
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (13)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Early detection of ossification of the posterior longitudinal ligament (OPLL) is hampered by the late onset of neurological symptoms, so we built and validated an interpretable machine learning model to identify OPLL during routine health examinations. We retrospectively analyzed 1442 Japanese adults screened between 2020 and 2023, including 432 imaging-confirmed cases, after median imputation, one-hot encoding, Random Forest feature selection that reduced 235 variables to 20, and class-balance correction with SMOTE. Logistic regression, Random Forest, Gradient Boosting, and XGBoost models were tuned using a 5-fold cross-validated grid search, in which a re-estimated logistic regression yielded odds ratios for clinical interpretation. The logistic model achieved 65% accuracy and an AUROC of 0.69 (95% CI 0.66–0.76), matching tree-based models, yet with fewer false-negatives. Advanced age (OR 1.60, 95% CI 1.27–2.00) and elevated CA19-9 (OR 1.24, 95% CI 1.00–1.35) independently increased OPLL odds. This concise, explainable tool could facilitate early recognition of OPLL, reduce unnecessary follow-up, and enable timely preventive interventions in high-volume screening programs.
Year:
2025
Year:
2025
Year:
2025
Objective Following intracordal trafermin injection for unilateral vocal fold paralysis, some patients require further treatment owing to poor voice improvement. This study aimed to identify the pre‐injection factors predictive of the effectiveness of intracordal trafermin injection for unilateral vocal fold paralysis. Methods This retrospective study evaluated the medical records of 308 patients diagnosed with unilateral vocal fold paralysis who received intracordal trafermin injections at the Tokyo Voice Center between 2012 and 2024. Data from 143 patients were finally analyzed. To predict the efficacy of intracordal trafermin injection on voice improvement prior to trafermin administration, several related factors were evaluated: age, sex, causative diseases, and pre‐ and post‐injection data, including the maximum phonation time (MPT), pitch range (PR), mean flow rate (MFR), and voice handicap index (VHI). Patients were divided into two groups depending on whether additional treatment was not (Group A) or was (Group B) required after the first injection. Results MPT, PR, and MFR differed significantly between Group A and Group B ( p < 0.01, 0.02, and 0.01, respectively); subsequently, cutoff values were calculated using these parameters. The cutoff values were 3.25 s for MPT, 20.5 semitones for PR, and 597.8 mL/s for MFR. Logistic regression showed no significant differences in any of the factors. Conclusion The pre‐injection MPT, PR, and MFR may help guide decisions regarding of intracordal trafermin injection in the treatment of unilateral vocal fold paralysis. These factors could help inform optimal treatment decision making for patients. Level of Evidence 4.
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (4)
Mitsuru Yagi
Professor
International University of Health and Welfare
Hitomi Kurosu
Senior researcher
National Institute of Infectious Diseases
Jungo Imanishi
Associate Professor
Teikyo University
Kenichi Tsujita
Professor of Medicine
Kumamoto University
Make your next move.
Prepare your application
Review drafts before you send them.